Lasa Supergenerics - Quaterly Results

13 Aug 2025 Evaluate
The sales slipped to Rs. 200.12 millions, down -35.10% for the June 2025 quarter as against Rs. 308.36 millions during the year-ago period.The Net Loss for the quarter ended June 2025 is Rs. -211.20 millions as compared to Net Loss of Rs. -27.32 millions of corresponding quarter ended June 2024Operating profit Margin for the quarter ended June 2025 slipped to -3.68% as compared to 18.02% of corresponding quarter ended June 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 200.12 308.36 -35.10 200.12 308.36 -35.10 1424.48 1043.35 36.53
Other Income 1.34 0.05 2580.00 1.34 0.05 2580.00 50.12 1.02 4813.73
PBIDT -3.68 18.02 -120.42 -3.68 18.02 -120.42 112.77 22.64 398.10
Interest 0.26 8.72 -97.02 0.26 8.72 -97.02 26.92 19.32 39.34
PBDT -209.69 9.30 -2354.73 -209.69 9.30 -2354.73 -70.84 -84.41 -16.08
Depreciation 15.70 27.94 -43.81 15.70 27.94 -43.81 123.00 106.73 15.24
PBT -225.39 -18.64 1109.17 -225.39 -18.64 1109.17 -193.84 -191.14 1.41
TAX -14.19 8.68 -263.48 -14.19 8.68 -263.48 -46.26 26.18 -276.70
Deferred Tax -14.19 8.68 -263.48 -14.19 8.68 -263.48 -46.26 26.18 -276.70
PAT -211.20 -27.32 673.06 -211.20 -27.32 673.06 -147.58 -217.32 -32.09
Equity 501.01 501.01 0.00 501.01 501.01 0.00 501.01 501.01 0.00
PBIDTM(%) -1.84 5.84 -131.47 -1.84 5.84 -131.47 7.92 2.17 264.84

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×